[Podcast] Interview with Genomics, Inc Founder Bob Ragot

This episode Bob and I talked about one of the most exciting new opportunities in pharmacist led clinical services: pharmacogenomic testing.

Pharmacogenomics is a dynamic industry that pharmacists are well-positioned to inherit.

Some key takeaways from our discussion:

• Why PGx has failed in the community pharmacy and in acute care settings in the past
• Moving away from the traditional third party billing model
• How developing genetic tests will become the model for comprehensive Pharmacogenetic detection and informed treatment
• How limiting scope of testing alleviates prescriber hesitation due to liability issues
• How can pharmacists act as the gatekeepers for the patient's comprehensive report
• Using pre-emptive genotyping to reduce trial and error prescribing
• How PGx testing allows Pharmacogenetic and the therapeutic considerations that can improve treatment outcomes and quality of life
• Enhancing the safety and effectiveness of anticoagulation drugs